Iktos and Curreio Announce Collaboration Agreement in New Drug Discovery

In this collaboration, Iktos’ de novo generative design technology in combination with Curreio’s state-of-the-art cryo-EM platform will be used...

June 09, 2023 | Friday | News
FDA Committee Unanimously Recommends Nirsevimab as First RSV Immunization for Infants

Nirsevimab would be the first immunization specifically designed to protect all infants through their first RSV season, if approved Across all clinical ...

June 09, 2023 | Friday | News
SCIEX launches the Intabio ZT system

SCIEX, a global leader in life science analytical technologies, launches the Intabio ZT system, the first fully-integrated microfluidic chip-based platform...

June 06, 2023 | Tuesday | News
MEDiC Life Sciences Announces Collaboration with Bristol Myers Squibb on Tumor Target Discovery

“We are very excited that Bristol Myers Squibb selected MEDiC as a collaborator to advance its oncology discovery programs,” said Kyuho Han, Ph...

June 06, 2023 | Tuesday | News
BullFrog AI Expands Licensing Agreement with Johns Hopkins Applied Physics Lab to Enhance AI Platform

“We are committed to firmly establishing BullFrog AI as the undisputed leader in artificial intelligence-driven drug development,” said Vin Sin...

June 06, 2023 | Tuesday | News
Merck Increases Global Commitment to Biosafety Testing With € 35 Million Investment in Scotland

Responds to global demand for biosafety testing for drug development and commercialization Expansion creates nearly 500 new jobs in Glasgow and Stirling...

May 31, 2023 | Wednesday | News
Ascentage Pharma's Olverembatinib Recommended for Second Breakthrough Therapy Designation in China for SDH-Deficient GIST

This marks the second BTD granted to olverembatinib by the CDE, with the first one granted in March 2021 for the treatment of patients with chronic-phase c...

May 31, 2023 | Wednesday | News
SK bioscience Receives Marketing Authorization for its COVID-19 Vaccine from UK MHRA

 SKYCovion is the world’s first-ever vaccine developed using the RoseTTAFold, a software tool that uses deep learning. SK bioscience has appl...

May 30, 2023 | Tuesday | News
Immutep Selects Charles River Laboratories for IMP761’s GLP Toxicology Study

Appointment of Charles River Laboratories ("Charles River") to run Immutep’s preclinical toxicology study evaluating the safety and toxicity of IMP...

May 30, 2023 | Tuesday | News
Sun Pharma and Philogen Partner for Exclusive Distribution, License, and Supply of NIDLEGY™ in Europe, Australia, and New Zealand

Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...

May 30, 2023 | Tuesday | News
Iovance Biotherapeutics' Lifileucel for Advanced Melanoma Receives FDA Acceptance

First Potential Approval of an Individualized, One-Time Cell Therapy  for Patients with Advanced Melanoma Iovance Biotherapeutics, Inc. (NASDAQ: IOVA...

May 29, 2023 | Monday | Regulatory
KEYTRUDA® + LENVIMA® Show Long-Term Survival Benefit in Advanced Renal Cell Carcinoma

After four years of follow-up, KEYTRUDA plus LENVIMA reduced the risk of death by 21% versus sunitinib in the pivotal Phase 3 CLEAR (Study 307)/KEYNOTE-581...

May 26, 2023 | Friday | News
Takeda and HUTCHMED's Fruquintinib NDA for Metastatic Colorectal Cancer Gets Priority Review

— Prescription Drug User Fee Act (PDUFA) Target Action Date set for November 30, 2023 — — NDA includes results from the Phase III FRESCO...

May 26, 2023 | Friday | News
Indivior Receives FDA Approval for OPVEE® Nasal Spray, Opioid Overdose Rescue Medicine

In the 12-month period ending in December 2022, over 79,000 people in the U.S. were reported to have died of an opioid overdose, of whi...

May 23, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close